While B-CLL cells exhibited low levels of this ILT2, it was upregulated in the NK cells of CLL patients (n = 60) compared to normal individuals (n = 25), which was associated with the severity of disease. The gene discussed is LILRB1; the disease is B-cell chronic lymphocytic leukemia.